Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;311(1):e233188.
doi: 10.1148/radiol.233188.

Caution on the CONTRRAST Trial

Sarah Eskreis-Winkler  1 , Maxine S Jochelson  1 , Katja Pinker  1 , Janice S Sung  1 , Christopher Comstock  1
Affiliations

Caution on the CONTRRAST Trial

Sarah Eskreis-Winkler et al. Radiology. 2024 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: S.E.W. No relevant relationships. M.S.J. Speaker honorarium from GE HealthCare. K.P. Grants from Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED) H2020 Research and Innovation Framework Program (PHC-11-2015 #667211-2); A Body Scan for Cancer Detection using Quantum Technology (CANCERSCAN) (H2020-FETOPEN #828978); Multiparametric 18F-Fluoroestradiol PET/MRI coupled with Radiomics Analysis and Machine Learning for Prediction and Assessment of Response to Neoadjuvant Endocrine Therapy in Patients with Hormone Receptor+/HER2− Invasive Breast Cancer Jubiläumsfonds of the Austrian National Bank (18207); Vienna Science and Technology Fund (LS19-046); MSKCC 2020 Molecularly Targeted Intra-Operative Imaging Award; Breast Cancer Research Foundation June 2019 to May 2021; NIH (UG3 CA239861); NIH (R01 CA249893); NIH (1R01CA270018-01A1); supported in part through the NIH/NCI Cancer Center (P30 CA008748); MSK has institutional financial interests relative to GRAIL; consultancy from Genentech, Merantix Healthcare, Aura Health Technologies, Guerbet; speakers bureaus fees from European Society of Breast Imaging, Bayer, Siemens Healthineers, DKD, Olea Medical, and Roche; support for travel and/or meetings from European Society of Breast Imaging; participation on a DataSafety Monitoring Board from Guerbet, Bayer; executive board membership, EUSOBI. J.S.S. No relevant relationships. C.C. Personal fees for advisory board from Bayer; consultant for Guerbet; speakers bureau fees from GE Medical.

References

    1. Phillips J , Mehta TS , Portnow LH , Fishman MDC , Zhang Z , Pisano ED . Comparison of Contrast-enhanced Mammography with MRI Utilizing an Enriched Reader Study: A Breast Cancer Study (CONTRRAST Trial) . Radiology 2023. ; 309 ( 2 ): e230530 . - PubMed
    1. Phillips J , Mehta TS , Portnow LH , Fishman MDC , Zhang Z , Pisano ED . Comparison of Contrast-enhanced Mammography with MRI Utilizing an Enriched Reader Study: A Breast Cancer Study (CONTRRAST Trial) . Radiology 2023. ; 309 ( 2 ): e230530 . - PubMed
    1. Pötsch N , Vatteroni G , Clauser P , Helbich TH , Baltzer PAT . Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis . Radiology 2022. ; 305 ( 1 ): 94 – 103 . - PubMed
    1. Xiang W , Rao H , Zhou L . A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer . Thorac Cancer 2020. ; 11 ( 6 ): 1423 – 1432 . - PMC - PubMed
    1. Jochelson MS , Pinker K , Dershaw DD , et al. . Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study . Eur J Radiol 2017. ; 97 : 37 – 43 . - PubMed

LinkOut - more resources